SP 500 Edges Higher as Utilities Lead Communication Services Drag AIPowered Drug Discovery Shows Potential for Brain Condition Treatments Like MND UK Egg Prices Surge Six Supermarket Eggs Now Cost Significantly More Than 1 AnheuserBusch InBev Shares Dip as Quarterly Sales Miss Analyst Expectations Consumer Sentiment Falls to Record Low in May as Rising Gas Prices Amid Iran Conflict Weigh on Outlook Market Digest Lowes Aptiv Zoetis in Focus AMST Q1 2026 Earnings Loss Per Share of 016 as Shares Decline Sharply First Citizens BancShares FCNCA Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations SDGR Q1 2026 Earnings Loss Widens Amid Software Transition Stock Rises Navient Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Higher SCL Q1 2026 Earnings Slight EPS Beat Drives Positive Market Response Capital City Bank Group CCBG Q1 2026 Earnings EPS Surges Past Estimates Amid Solid Core Operations Park National Corporation PRK Holds Steady Above Key Support Resistance in View Agilent Technologies A Edges Higher Amid Steady Trading Key Levels to Watch Yatra Online YTRA Surges 6 as Buying Momentum Builds Near Key Support Sasol Ltd SSL Edges Higher Amid Sector Volatility Support and Resistance Levels in Focus HCM III Acquisition Corp HCMA Edges Higher as SPAC Market Shows Mixed Signals GFR Q1 2026 Earnings Negative EPS Disclosed Amid Limited Data Stock Rises 118 Array Digital Infrastructure Inc AD Q1 2026 Earnings Massive EPS Beat Drives Optimism Amid Cautious Outlook TWOD Q1 2026 Earnings Strong EPS Surprise of 2947 Delivers Beat FENC Q1 2026 Earnings Unexpected Profitability Surprises Market Stock Edges Lower Neogen Corporation NEOG Q1 2026 Earnings Strong Profit Beat Offsets Flat Revenue CLLS Q1 2026 Earnings NarrowerThanExpected Loss as GeneEditing Pipeline Advances China Industrial Profits Surge 247 in April Fastest in Two Years Amid Export Boost SUNation Energy Inc SUNE Q2 2024 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Revenue Uncertainty Jupiter Neurosciences Jumps 135 as Speculative Interest Builds in SmallCap Biotech